For those who believe that NWBO is overvalued, or even properly valued, please show me even one bioteck who could gain approval on a blockbuster drug on any day that's has a market cap as low, or lower than NWBO's. I suspect that you'll find market caps in the low billions are far more likely than under $.4 billion where we currently reside.
Look at a company like AVXL, which I'm also invested in. It's just applied for European approval, it probably won't happen till 2026, yet it's market cap is more than double that of NWBO. I suspect that by the time it's approved it's market cap will be roughly the $4 billion that Analysts have set its target price at.
Of course none of this places any value on the legal suit, and that could add no telling how much to our market cap.
Gary
Bullish
Market Data 
Markets 
AI
